RxDoctor Payments Data

Anthony Curiale, PA

Medical · Fair Bluff, NCNPI 1780729814

Payments from drug & device makers

$614in general payments, 2019–2025

Across 42 payments — averaging $14.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$186
  • Ardelyx, Inc.$81
  • AstraZeneca$62
  • Pfizer$62
  • Boehringer Ingelheim$49
  • Novo Nordisk$36
  • plus $139 from 8 others

What the payments were for

  • Food & beverage$614100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$614 in reported general payments places this provider in the 55th percentile of 878 medical providers in North Carolina.

See all medical providers in North Carolina

Medicare billing

Part B allowed, 2024
$24,714
Medicare patients
86
Services billed
422

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban132$98,526
TrulicityDulaglutide65$80,116
LinzessLinaclotide113$77,102
OzempicSemaglutide70$76,564
JardianceEmpagliflozin58$64,423
FarxigaDapagliflozin Propanediol55$43,106
Stiolto RespimatTiotropium Br/Olodaterol Hcl35$24,005
Trelegy ElliptaFluticasone/Umeclidin/Vilanter26$23,825
RybelsusSemaglutide14$23,333
JanumetSitagliptin Phos/Metformin Hcl29$21,136
JanuviaSitagliptin Phosphate19$19,835
XareltoRivaroxaban27$19,406
Combivent RespimatIpratropium/Albuterol Sulfate22$16,128
MounjaroTirzepatide14$15,820
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen504$15,195

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Stiolto Respimat, Combivent Respimat, Spiriva Respimat, Tradjenta$49$130,991152 claims
Novo NordiskOzempic, Rybelsus$36$99,89784 claims
PfizerEliquis$62$98,526132 claims
AbbVieLinzess$20$77,102113 claims
AstraZenecaFarxiga, Symbicort$62$47,96177 claims
MerckJanumet, Januvia, Janumet Xr$26$46,09263 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta$15$39,88461 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 878 medical providers in North Carolina.

Other medical in Fair Bluff

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →